Similarly key G1 checkpoint arrest genes, such as CDKN2B, RBL2, CDK5RAP1, and CCNC, coincided with the delayed G1/S transition observed in CP CML progenitors, which also harbored longer G1 transit times. The gene discussed is RBL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.